Материал из hpluswiki
Перейти к навигации Перейти к поиску

Vascular endothelial growth factor receptor 2 precursor (EC (VEGFR-2) (Fetal liver kinase 1) (FLK-1) (Kinase insert domain receptor) (KDR) (Protein-tyrosine kinase receptor flk-1) (CD309 antigen) [FLK1] [VEGFR2]


Regulation of endothelial progenitor cell differentiation and function by dimethylarginine dimethylaminohydrolase 2 in an asymmetric dimethylarginine-independent manner.

Endothelial progenitor cells (EPCs) are involved in the repair of vessels and angiogenesis and are useful in the treatment of ischemic diseases. The dimethylarginine dimethylaminohydrolase (DDAH)/asymmetric dimethylarginine (ADMA) pathway is regulated by silent information regulator 1 (SIRT1), leading to the senescence of endothelial cells (ECs). Here, we demonstrated that peripheral blood EPCs predominantly expressed DDAH2 that increased with EPC differentiation. EPC senescence and dysfunction were induced on interruption of DDAH2 expression, whereas the mRNA expression of vascular endothelial growth factor (VEGF) and kinase-domain insert containing receptor (KDR) were downregulated. Moreover, SIRT1 expression increased with EPC differentiation. Interruption of SIRT1 inhibited DDAH2, VEGF, and KDR expression, but had no effect on the level of ADMA. From our data, we concluded that DDAH2 is involved in the differentiation of EPCs and regulates the senescence and function of EPCs through the VEGF/KDR pathway by activation of SIRT1.

MeSH Terms

  • Amidohydrolases
  • Arginine
  • Cell Differentiation
  • Cells, Cultured
  • Cellular Senescence
  • Endothelial Progenitor Cells
  • Humans
  • RNA Interference
  • RNA, Messenger
  • RNA, Small Interfering
  • Sirtuin 1
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factor Receptor-2


  • SIRT1
  • dimethylarginine dimethylaminohydrolase
  • endothelial progenitor cells
  • senescence